# Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

> **NCT05990881** · PHASE3 · RECRUITING · sponsor: **Rhode Island Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Carpometacarpal Sprain
- Thumb Sprain
- Clostridium; Botulinum

## Interventions

- **DRUG:** Botulinum toxin
- **DRUG:** Standard-of-care corticosteroid injections

## Key facts

- **NCT ID:** NCT05990881
- **Lead sponsor:** Rhode Island Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-27
- **Primary completion:** 2025-12
- **Final completion:** 2026-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05990881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05990881, "Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05990881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*